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Methicillin-resistant Staphylococcus aureus (MRSA) is no longer only hospital acquired. MRSA is defined
as community acquired if the MRSA-positive specimen was obtained outside hospital settings or within 2
days of hospital admission, and if it was from a person who had not been hospitalized within 2 years
before the date of MRSA isolation. To estimate the proportion of community-acquired MRSA, we analyzed
previous hospitalizations for all MRSA-positive persons in Finland from1997 to 1999 by using data from
the National Hospital Discharge Register. Of 526 MRSA-positive persons, 21% had community-acquired
MRSA. Three MRSA strains identified by phage typing, pulsed-field gel electrophoresis, and ribotyping
were associated with community acquisition. None of the strains were multiresistant, and all showed an
mec hypervariable region hybridization pattern A (HVR type A). None of the epidemic multiresistant hospi-
tal strains were prevalent in nonhospitalized persons. Our population-based data suggest that community-
acquired MRSA may also arise de novo, through horizontal acquisition of the mecA gene. 
ethicillin-resistant  Staphylococcus aureus (MRSA) is
an important cause of nosocomial infections world-
wide. Recent studies suggest that the epidemiology of MRSA
may be changing, as the isolation of MRSA is no longer lim-
ited to hospitalized patients or persons with predisposing risk
factors (1–4). However, the prevalence of MRSA colonization
in healthy persons in the community has been shown to be low,
even when MRSA is highly endemic in hospital settings (5). 
Nosocomial MRSA strains in the community, including
nursing homes and other nonacute-care  facilities, may be
transmitted by discharged patients and health-care workers
(6,7). Whether strains of MRSA in the community also arise
de novo, as a consequence of horizontal acquisition of the
mecA gene, is unclear. The transfer of mecA DNA to a suscep-
tible S. aureus strain has occurred in vitro (8) and recently in a
hospitalized patient during antibiotic treatment (9). The mech-
anism of transfer of mec DNA from a donor to a recipient is
not completely understood. However, the excision and integra-
tion of the mec DNA from and to the chromosome are appar-
ently catalyzed by cassette chromosome recombinases A and
B (Ccr A and B) coded by mec-associated genes (ccrA and B),
with homology to the invertase-resolvase family of DNA
recombinases (10). 
In Finland, the prevalence of MRSA has remained low,
although several hospital epidemics have occurred in the last
decade (11). We recently recognized two distinct groups of
MRSA, one representing multiresistant epidemic strains and
the other only β -lactam-resistant strains. These two groups
also showed differences in ribotypes and mec determinant pro-
files (12). The aim of this study was to estimate the proportion
of community-acquired MRSA by analyzing the hospital con-
tacts of persons from whom MRSA was found from 1997 to
1999. We also compared the MRSA isolates in persons with
and without hospital contact in terms of strain type (deter-
mined by phage typing, pulsed-field gel electrophoresis
[PFGE], and ribotyping), antibiotic resistance, and mec deter-
minant profile. 
Materials and Methods
Surveillance and Typing Scheme of MRSA
Finnish microbiology laboratories report (generally elec-
tronically) all MRSA isolations to the National Infectious Dis-
ease Register at the National Public Health Institute (KTL).
The KTL records the date, source of specimen, and the
patient’s birth date, sex, and place of treatment. Using this
information and a time interval of 36 months, multiple isola-
tions from the same person are deleted from the database. The
microbiology laboratories also send the MRSA isolates to the
Laboratory of Hospital Bacteriology at KTL for further analy-
sis. Phage typing, PFGE, and antimicrobial drug susceptibility
testing were performed as described (11). In brief, phage typ-
ing was performed with the universal set of phages (13) at 1x
and 100x routine test dilutions, both with and without heat
treatment of bacteria (14). Antimicrobial drug susceptibilities
were tested by the disk diffusion method according to guide-
lines recommended by the National Committee for Clinical
Laboratory Standards (NCCLS). The antibiotics tested were
oxacillin, ampicillin, penicillin, cephalexin, cefuroxime, gen-
tamicin, tobramycin, erythromycin, clindamycin, chloram-
phenicol, ciprofloxacin, rifampicin, fusidic acid, mupirocin,
and vancomycin. MICs of oxacillin were determined by E-test
(AB Biodisk, Solna,  Sweden)  according to manufacturer’s
instructions. If the oxacillin MIC was <64 µg/mL, methicillin
resistance was verified with the MRSA screen test (Denka
Seiken, Japan) or mecA-polymerase chain reaction (15). For
PFGE, genomic DNA prepared in agarose blocks was digested
with  SmaI restriction endonuclease, and chromosomal *National Public Health Institute, Helsinki, Finland
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fragments were separated with a Chef DR III (Bio-Rad Labo-
ratories, Hercules, CA) for 24 hours with initial and final
switching times of 10 seconds and 60 seconds, respectively.
PFGE profiles differing by fewer than four bands were inter-
preted as identical or closely related (16). Bionumerics soft-
ware, with Dice coefficient and unweighted pair group
matching average for clustering, and optimization and toler-
ance values of 1% and 1%–2%, respectively, were used to ver-
ify the relatedness of PFGE profiles. MRSA isolates sharing
identical or closely related PFGE profiles and phage types
were considered to be the same strain type. If the PFGE pro-
files were related, but the phage types were different, ribotyp-
ing with one to three restriction enzymes (HindIII, EcoRI,
ClaI) was performed to verify the relatedness of isolates (11).
Riboprofiles with fewer than four bands’ difference were
regarded as identical or closely related. The genomic variation
within the mec determinant hypervariable region (HVR) was
analyzed for a subset of MRSA isolates as described (12). In
brief, the two probes which were prepared from plasmid
pBBB30 (17) recognize the mec hypervariable region. The
probes are hybridized with genomic bacterial DNA which is
first digested with EcoRI and BglII.
Study Population, MRSA Isolates, and Definitions
All MRSA-positive persons in Finland from 1997 to 1999
and their MRSA isolates (one from each) were included in the
study. A sporadic strain was defined as a strain type isolated
from one person only. An MRSA isolate was defined as hospi-
tal acquired if the MRSA-positive specimen was obtained 2
days after hospital admission, and for discharged patients, if
the patient had been hospitalized within 2 years before the date
of MRSA isolation. 
Previous Contacts with a Health-Care Facility
National identity codes for each person with an MRSA-
positive culture were obtained either through the primary diag-
nostic laboratory or from the infection control nurse of the
health-care facility. Based on the first isolation date of MRSA
and the national identity code, data on previous hospitaliza-
tions within 2 years before the MRSA isolation date were
retrieved from the National Hospital Discharge Register
(HILMO). The HILMO is a civil register comprising compre-
hensive health-care records, provided by all hospitals and
health-care centers in Finland, including outpatient  surgery.
Each report to the register includes patient identity informa-
tion, admission and discharge dates, a code of the health-care
provider, type of service, specialty, the place (home or institu-
tion) from which the patient came to the institution, and data
on surgical procedures.
Additional background information was collected for per-
sons for whom no HILMO reports could be found by sending
questionnaires to infection-control nurses at relevant health-
care facilities. The information collected included 1) whether
the MRSA-positive person was a patient or a staff member, 2)
whether the specimen was taken on clinical or screening basis,
and 3) whether the screening sample was taken because of a
hospital contact abroad or because of an epidemic situation.
Statistical Analysis and Ethical Aspects 
For categorical variables, proportions were compared by
the chi-square test with Yates correction or Fisher’s exact test,
as appropriate. The means and medians of the continuous vari-
ables were compared by the Student’s t test or Mann-Whitney
U test, depending on the sample distribution.
With approval from the Ministry of Social Affairs and
Health and the Finnish data protection authority, the National
Research and Development Centre for Welfare and Health
gave permission to use the data from the HILMO register. 
Results
From 1997 to 1999, 520 MRSA isolations were reported to
the National Infectious Disease Register; the annual incidence
ranged from 2.3 to 4.1/100,000 persons. The Laboratory of
Hospital Bacteriology received MRSA isolates from 529 per-
sons. Three persons did not have a Finnish national identity
code and were excluded from the study. The median age of the
526 persons was 51 years (range <1–96), and 291 (55%) were
male. 
Contacts with Health-Care Facilities
Of the 526 MRSA-positive persons, 108 (21%) did not
have any verified link to health-care facilities 2 years before
the MRSA isolation date, including 17 persons whose MRSA
was isolated within 2 days of hospital admission. Their MRSA
isolates were classified as community acquired. BEcause of
signs of infection or clinical findings, specimens were taken
from 69 persons and, 37 persons were specifically screened for
MRSA. Of those 37, 21 had a known MRSA contact in their
family, 13 were otherwise exposed to a known MRSA carrier,
and 3 were known to have carried MRSA previously. 
The HILMO register and the questionnaire survey showed
418 (79%) persons who had at least one connection to a hospi-
tal, and their MRSA isolates were classified as hospital
acquired. According to the HILMO register, 376 persons were
hospitalized in Finnish hospitals within 2 years before the
MRSA isolation date: 156 hospitalized patients with MRSA
isolated 2 days after hospital admission and 220 discharged
patients. The time frame between the MRSA isolation date and
the previous hospitalization for the discharged patients was <6
months for 156 (71%) patients, 6 to 12 months for 36 (16%),
and >12 months for 28 (13%) patients. The questionnaire sur-
vey identified 42 additional persons who had an obvious con-
tact with a hospital, including 23 staff members (12 working in
a Finnish health-care facility and 11 who had recently worked
abroad) and 19 patients, 15 of whom had recently been hospi-
talized outside Finland. 
The median age of the persons who did not have a contact
with a health-care facility was lower than that of persons who
had contact (34 vs. 58 years, p<0.01). The proportion of chil-
dren <15 years of age was higher in community-acquired thanRESEARCH
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in hospital-acquired MRSA strains (27 [25%] of 108 vs. 31
[7%] of 418, p<0.01). 
Strain Types
Among the 526 MRSA isolates, our typing scheme
showed 84 strain types, 56 (67%) of which were sporadic and
28 (33%) shared by at least two persons. The distribution of
sporadic (in total 56 [11%] of 526) and shared (in total 470
[89%] of 526) strain types was similar in persons with and
without connections to health-care facilities (Table 1). 
Fourteen strain types, each of which were isolated from
>10 persons, represented 421 (80%) of 526 MRSA isolations
(Table 2, Figure). Three of the 14 most common strain types
were more likely to be found in persons who did not have a
contact with a health-care facility than in those who had such a
contact: Mikkeli clone (41 [38%] of 108 vs. 75 [18%] of 418,
p<0.01), E31 (10 [9%] of 108 vs. 6 [1%] of 418, p<0.01), and
E22 (8 [7%] of 108 vs. 7 [2%] of 418, p<0.01). 
Of all strains isolated from persons who had no hospital
contact, 94% were nonmultiresistant. In addition, of the 14
most common strain types, all 7 nonmultiresistant strains, but
none of the multiresistant strains, showed HVR type A (Table
2). Of the 56 sporadic MRSA strains, 41% were nonmultiresis-
tant, including all but one of the strains isolated from persons
without connections to hospitals (Table 1).
Discussion
Our population-based study showed that from 1997 to
1999 one fifth of all Finnish MRSA isolates came from per-
sons who had no connection to health-care facilities, suggest-
ing that these MRSA isolates may be community acquired.
Three strain types identified by phage typing, PFGE, and
ribotyping were associated with community acquisition, and
none of these strain types were multiresistant. 
To our knowledge, this is the first report of community-
acquired MRSA on the national level. Previous reports have
focused on single health-care institutions or certain restricted
areas (1,3,6,12,18-20). Both data sources used in our study, the
surveillance and typing scheme of MRSA and the hospital dis-
charge register, were nationwide (20). The availability of
national identity codes allowed us to link the two data sources
and to study one MRSA isolate per person. The number of iso-
lates routinely typed and verified as MRSA was equal to that
of MRSA isolations reported to the National Infectious Dis-
ease Register, suggesting that the isolates of MRSA available
for typing were nationally representative.
Community-acquired MRSA can be classified into the fol-
lowing categories: discharged hospital patients with MRSA,
nursing-home residents with MRSA, MRSA transmitted to
nonhospitalized patients, and MRSA arising de novo in the
community (7). The first three categories include MRSA iso-
lates of health-care facility origin, which are thought to repre-
sent a limited number of different genotypes, disseminate
clonally, and express resistance to multiple antibiotics (1,21–
23). De novo MRSA strains, in contrast, are thought to arise
through acquisition of mec DNA into a previously susceptible
S. aureus genotype (7,9,24). Our study focused on the last two
categories. We first identified nonhospitalized MRSA-positive
persons and thereafter compared their strains with those found
in hospitalized patients. 
Based on our study, the proportion (21%) of community-
acquired MRSA was relatively high in Finland. However, the
definition of community-acquired MRSA is not straightfor-
ward. The definition classically includes MRSA isolated out-
side hospital settings or from a patient within 48 to 72 hours of
hospital admission. Because of the long-term persistence of
MRSA colonization (25), contacts with hospitals or nursing
homes before MRSA isolation should also be taken into
account (6,19,26). Therefore, our definition of community
acquisition covered a 2-year time period without a health-care
facility contact before the MRSA isolation. If the cut-off
period had been 1 year, the proportion of community-acquired
isolates would have been 26%. If the questionnaire survey on
the additional background data had not been performed, the
proportion would have been 29%. Although this questionnaire
survey was not comprehensive, it allowed us to characterize
the persons who had no reports in the discharge register and to
identify persons with a foreign or ongoing hospital contact. 
Most community-acquired MRSA strains were nonmulti-
resistant, and children were more likely to have a community-
than a hospital-acquired MRSA. These findings agree with
those of previous reports, suggesting that nonmultiresistant
MRSA is emerging as an important pathogen in the commu-
nity (1,18,22,23). The majority (64%) of community-acquired
strains were isolated on a clinical basis. However, one third of
all community-acquired strains were isolated because of
screening of persons exposed to a known MRSA carrier, most
of whom were family members. Most exposed persons had the
same strain type as their contacts (data not shown). 
Among the 14 most common strain types, which represent
80% of all MRSA isolates, we identified 7 nonmultiresistant
strain types showing a hypervariable region hybridization pat-
tern A. Three of these strain types were associated with com-
munity acquisition and represented more than half of all
community-acquired strains. In addition, three other strain
types were frequently found in persons without connections to
hospitals. The only exception was the internationally recog-
nized UK EMRSA-15 (27), which was isolated mainly from
patients or health-care workers who had recently returned
from hospitals abroad. In contrast, the multiresistant strain
types, including the UK EMRSA-16 (28) and the Iberian clone
Table 1. Distribution of sporadic strains of methicillin-resistant 
Staphylococcus aureus (MRSA) and strains shared by at least two 
persons and contact with a health-care facility, Finland
Persons with 
hospital contact (%) 
Persons without 
hospital contact (%)
n=418 n=108
Sporadic strain types 43 (10) 13 (12) 
Strain types shared by at 
least two persons
375 (90) 95 (88)Emerging Infectious Diseases  •  Vol. 8, No. 6, June 2002 605
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(29), were almost exclusively found in persons who had con-
tacts with hospitals.
Despite the fact that the HVR type A seems to coincide
with nonmultiresistance, the hypervariable region itself has not
been shown to contain any antibiotic resistance markers
(17,30,31). Some of the multiresistant strains actually have
deletions in this area (31). The hypervariable region has been
analyzed by polymerase chain reaction and sequencing to dis-
tinguish different mec DNA types (32,33). The method identi-
fied five different subclones in 50 isolates representing one
epidemic strain in Germany (33).
Our study had several limitations. First, some of the
MRSA isolates classified as community acquired may have
been isolated from nursing-home residents, since not all Fin-
nish nursing homes report to the National Discharge Register.
The possibility of misclassification concerns a small number
of isolates, since only 10 of all persons with community-
acquired MRSA were >64 years of age. Second, the differ-
ences in local sampling policies may affect the number and
type of community-acquired MRSA identified. National
guidelines for MRSA prevention in Finland are primarily
directed to hospital use, and sampling and screening policies
in community setting are not specified. Third, we did not
gather clinical data and risk factors (6,34,35) other than previ-
ous hospital stays for MRSA acquisition. Further information
should be collected from persons with community-acquired
MRSA to develop a hypothesis on risk factors specific for
community acquisition.
In conclusion, a large proportion of MRSA-positive per-
sons may have acquired their strains outside the hospital set-
ting, and their MRSA strains were nonmultiresistant, showed
an HVR type A, and differed genotypically from epidemic
strains found in hospitalized patients. None of the epidemic
multiresistant hospital strains were prevalent in nonhospital-
ized persons. Our findings suggest that MRSA may also
Table 2. Methicillin-resistant Staphylococcus aureus (MRSA) strains found in >10 persons in relation to contact 
with a health-care facility, 1997–1999, Finlanda
Strain type
Persons with 
hospital contact (%)
Persons without 
hospital contact (%) Total Multiresistanceb
HVR 
type
Yr first identified in 
Finland
Mikkeli clone (O11, E12)  75 (65) 41 (35) 116 No A 1993
E1  50 (98) 1 (2) 51  Yes D 1992
E24 49 (98) 1 (2) 50  Yes C 1998
E5 (UK EMRSA 16)  36 (100) 0 (0) 36  Yes C 1995
Kemi clone 25 (71) 10 (29) 35  No A 1996
E27 17 (65) 9 (35) 26  No A 1997
E31 6 (38) 10 (63) 16  No A 1997
E22 7 (47) 8 (53) 15  No A 1997
UK EMRSA-15  13 (93) 1 (7) 14  No A 1997
E19 13  (100) 0  (0) 13  Yes C 1997
Pori clone (O15) 8 (62) 5 (38) 13  No A 1993
E20 12  (100) 0  (0) 12  Yes C 1998
Iberian clone (E6, E7, E10, O8) 11 (92) 1 (8) 12  Yes B 1991
O25 12 (100) 0 (0) 12  Yes B 1997
aHVR, hypervariable region; E, epidemic, strain isolated in more than one health-care facility; O, outbreak, strain isolated in one health-care institute.
bResistance to more than three antibiotic groups in addition to β -lactams.
Figure. Pulsed-field gel electrophoresis (PFGE) profiles of the 14 most
common methicillin-resistant Staphylococcus aureus (MRSA) strain
types identified, Finland, 1997–1999. Lanes 1, 9, 17: S. aureus NCTC
8325 (molecular weight marker); lanes 2–4: strain types associated
with community acquisition (Mikkeli clone, E22, E31); lane 5: E1; lane
6: E24; lane 7: E5; lane 8: Kemi clone; lane 10: E27; lane 11: UK
EMRSA-15; lane 12: E19; lane 13: Pori clone; lane 14: E20; lane 15:
Iberian clone; and lane 16: O25.RESEARCH
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emerge as a community-acquired pathogen as a consequence
of horizontal acquisition of the mecA gene by a previously sus-
ceptible S. aureus strain type.
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